Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Clinical trial NCT03676504 · RECRUITING
Trial details
- NCT number
- NCT03676504
- Sponsor
- University Hospital Heidelberg
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2026-12-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.